4.5 Article

The influence of tamoxifen on normal mouse mammary gland homeostasis

Journal

BREAST CANCER RESEARCH
Volume 16, Issue 4, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s13058-014-0411-0

Keywords

-

Categories

Funding

  1. University of Cambridge, Cancer Research UK
  2. Hutchison Whampoa Limited
  3. Dutch Cancer Society [KWF 2013-6057]
  4. MacGillavry fellowship of the University of Amsterdam
  5. Cancer Research UK [10208] Funding Source: researchfish

Ask authors/readers for more resources

Introduction: Lineage tracing using inducible genetic labeling has emerged to be a powerful method for interrogating the developmental fate of cells in intact tissues. A common induction mechanism is the use of tamoxifen-dependent Cre recombinase (CreER and CreER(T2)), but the effects of tamoxifen at doses normally used in lineage-tracing studies on normal adult mammary gland homeostasis are not known. Methods: We used flow cytometry and immunostaining of intact glands to determine whether varying doses of tamoxifen skew the distribution and the apoptosis and proliferation status of different types of mammary epithelial cells in vivo. We also examined how tamoxifen influences the number of progenitor and mammary repopulating units (MRUs). Results: Our results indicate that >= 5 mg/25 g body weight of tamoxifen induces a transient increase in cell proliferation and in the number of basal cells in the adult mammary epithelium up to 7 days after tamoxifen administration. However, in the medium term (3 weeks), all doses of tamoxifen >= 1 mg/25 g body weight result in a decrease in the number of basal and EpCAM(+)CD49b(-) luminal cells and a decrease in progenitor cell function. Tamoxifen at doses >= 5 mg/25 g body weight induced a transient increase in caspase-3-mediated apoptotic cell death within the mammary epithelium. However, mammary epithelial cell numbers in all subpopulations were restored to their original levels by 8 weeks. No long-lasting effects of tamoxifen on MRU numbers or on pubertal ductal development were observed. Conclusion: Tamoxifen can skew the distribution of mammary cell types in a dose-dependent manner, and thus caution must be taken when interpreting lineage-tracing studies using high doses of tamoxifen, particularly when short-duration analyses of a quantitative nature are being performed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available